Erratum: Passardi, A. et al. Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study. Cancers 2019, 11, 663

Authors :: Martina Valgiusti
Giorgio Ercolani
Elisa Neri
Andrea Casadei Gardini
Andrea Casadei-Gardini
Giuliano La Barba
Antonino Romeo
Giovanni Luca Frassineti
Fabio Ferroni
G. Ghigi
Alessandro Passardi
Elisabetta Parisi
Emanuela Scarpi
Flavia Pagan
Source :: Cancers, Cancers, Vol 12, Iss 1, p 178 (2020)
Publication Year :: 2020
Publisher :: MDPI, 2020.
Abstract: The aim of the study was to evaluate the safety and efficacy of a new chemo-radiotherapy regimen for patients with locally advanced pancreatic cancer (LAPC). Patients were treated as follows: gemcitabine 1000 mg/m

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
medicine.medical_treatment
Phases of clinical research
GemOx
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
lcsh:RC254-282
Tomotherapy
Locally advanced pancreatic cancer
n/a
Internal medicine
Medicine
Erratum
business
Chemoradiotherapy

Tools